Clinical Trials Logo
  1. Home
  2. Acute Cholecystitis
  3. NCT06213740

Validation of a New Simplified Scoring System for Acute Calculous Cholecystitis — ACME  

Acute Cholecystitis Clinical Trial

Official title:
Validation of a New Simplified Scoring System (ACME) for Acute Calculous Cholecystitis

Clinical Trial Summary

Acute calculous cholecystitis (ACC) is the second most frequent surgical condition in emergency departments. The recommended treatment is surgical treatment (ST) and the accepted mortality is <1%, but in severe and/or fragile patients is higher. Despite the Tokyo Guidelines, there no consensus on who is the unfit patient for ST. A recent study has identified 4 risk factors that predicts the mortality in a 92% of patients (ACME) and could help to develop new guidelines in ACC. The aim of this study is this validation of the new simplified scoring system for mortality in ACC.

Clinical Trial Description

This is a retrospective single-center observational study of 387 adults with ACC during 2 non-consecutive years (2017/2021), including baseline demographic characteristics, comorbidity severity defined as Charlson Comorbidity Index (CCI), ASA Score, Tokyo Guidelines' severity classification and the new ACME Score. The primary outcome is to study the prediction of mortality of ACME score. Secondary outcomes include complications following Clavien-Dindo's classification, C-statistic, and ROC Curves. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT06213740
Study type Observational
Source Hospital del Mar
Contact
Status Completed
Phase
Start date January 8, 2021
Completion date December 17, 2021
View Details
See also
  Status Clinical Trial Phase
Completed NCT04156711 - Remote Ischemic Preconditioning in Patients Undergoing Acute Minor Abdominal Surgery N/A
Recruiting NCT02130245 - Acute Cholecystitis: Early Versus Delayed Laparoscopic Cholecystectomy; Randomized Prospective Study N/A
Completed NCT01942356 - Evaluation of Closed-loop TIVA Propofol, Sufentanil and Ketamine Guided by BIS Monitor N/A
Completed NCT04995380 - Validation and Comparison of Scores for Prediction of RIsk for Post-operative Major Morbidity After Cholecystectomy in Acute Calculous Cholecystitis (SPRIMACC)
Completed NCT03999645 - Is it Safe to do Laparoscopic Cholecystectomy for Acute Cholecystitis up to Seven Days? N/A
Completed NCT03296280 - Evaluation of Implementation of a National Point-of-Care Ultrasound Training Program
Completed NCT03002051 - EUS-guided Transenteric Drainage With a Novel Lumen-apposing Metal Stent N/A
Completed NCT00447304 - Acute Cholecystitis - Early Laparoscopic Surgery Versus Antibiotic Therapy and Delayed Elective Cholecystectomy Phase 3
Completed NCT04346550 - Comparison of Morbidity After Laparoscopic Cholecystectomy for Acutely Inflamed Gall Bladder With and Without Drain N/A
Active, not recruiting NCT04197908 - EUS-guided Gallbladder Drainage Instead of Laparoscopic Cholecystectomy for Acute Cholecystitis. A Feasibility Study. N/A
Completed NCT02027402 - Effects of Drainage in Laparoscopic Cholecystectomy N/A
Not yet recruiting NCT01706068 - Transient ECG Changes in Patients With Acute Biliary Disease N/A
Enrolling by invitation NCT04633512 - Safety and Feasibility of ActivSightTM in Human N/A
Completed NCT04672902 - Treatment of Mirizzi Syndrome
Completed NCT03122054 - Early Versus Delayed Cholecystectomy N/A
Recruiting NCT05732480 - Influence of Gut Microbiome in Gallstone Disease
Completed NCT04308265 - Scoring System in Acute Calculous Cholecystitis
Not yet recruiting NCT06287112 - Prevention of Acute Cholecystitis With ETGBD N/A
Recruiting NCT05709548 - Use of Indocyanine Green in Acute Cholecystitis Phase 4
Enrolling by invitation NCT02490293 - Is it Fair to Use Antibiotics After Laparoscopic Cholecystectomy for the Patients With Acutely Inflamed Gallbladder? N/A